secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001628280-24-020698
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn posts investor presentation; no material financial or pipeline updates disclosed
--------------------------------------------------------------------------------

- Company posted a corporate presentation to its website on May 6, 2024, for use in investor meetings.
- Presentation attached as Exhibit 99.1 contains cover slide only; no specific financial data, clinical milestones, or guidance provided.
- No changes to previously disclosed business strategy or pipeline status were announced.
- Filing contains no earnings results, regulatory actions, or material contracts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024020698/0001628280-24-020698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024020698/fhtx-20240506.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-020698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer